| Purpose | Announcement Date | Ex-Date | Record Date | Dividend Amount | Dividend per Share | Remark |
|---|---|---|---|---|---|---|
| Dividend | 4 Jun 2025 | 18 Sep 2025 | 18 Sep 2025 | 0.01 | 1 | Final |
| Outcome of the meeting of the Board of Directors held on Wednesday, June 04, 2025 The 1/- each Board fully recommended a Final Dividend of Rs. 0.01/- (1%) per equity share of Rs. This paid (subject to deduction of tax, if any) for the financial year 2024-25, General shall be paid subject to the approval of the shareholders at the ensuing Annual Meeting of the Company. | ||||||
| Dividend | 29 May 2024 | 23 Sep 2024 | - | 1 | 10 | Final |
| Shukra Pharmaceuticals Limited Equity Rs.1.0000 per share(10%)Final Dividend | ||||||
The contract, valued at ₹24.06 crore, includes the complete scope of supply along with packing, forwarding, insurance and delivery right up to the consignee site in Afghanistan.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
